Registration and prospectus / American Oncology Network, Inc. | Tables in SEC filings

AONC American Oncology Network, Inc.

IPO registration (amended)

The following table includes information relating to the securities held by the Selling Securityholders, including the price each Selling Securityholder paid for the securities, the potential profit relating to such securities and any applicable lock-up restrictions. The following table is in part based off AON’s internal records and is for illustrative purposes only. The table should not be relied upon for any purpose outside of its illustrative nature. The public offering price in DTOC’s IPO was $10.00 per share. Consequently, as seen in the table below, some of the Selling Securityholders may realize a positive rate of return on the sale of their Common Stock covered by this prospectus even if the market price per share of our Common Stock is below $10.00 per share, in which case the public shareholders may experience a negative rate of return on their investment.

Selling Securityholder	Number of Offered Securities	Effective Purchase Price per Offered Security	Potential Profit per Offered Security(1)	Aggregate Potential Profit(1)	Lock-Up Restrictions
Entities or persons affiliated with Digital Transformation Sponsor LLC and permitted transferees
Founder shares	8,337,500	$0.003	$6.30	$52,501,250	(2)
Private placement warrants	6,113,333	$1.50	$—	$—	N/A
Shares of Class A Common Stock underlying private placement warrants	6,113,333	$11.50(3)	$—	$—	(2)
AON LLC Equityholders
Class A Common stock	28,109,796	$10.00(4)	$—	$—	(5)
Holders of Series A Preferred Stock
Class A Common stock	8,601,203	$10.00(6)	$—	$—	N/A

	Three Months Ended September 30,		Change		Nine Months Ended September 30,		Change
(dollars in thousands)	2023	2022	$	%	2023	2022	$	%
Patient service revenue, net	$332,195	$293,612	$38,583	13.1%	$945,681	$840,507	$105,174	12.5%
Other revenue	4,110	3,712	398	10.7%	9,322	8,765	557	6.4%
Total revenue	$336,305	$297,324	$38,981	13.1%	$955,003	$849,272	$105,731	12.4%

	Year Ended December 31,
	2022	2021	2020
Current
Federal	$—	$(306)	$152
State	—	(20)	123
	—	(326)	275
Deferred
Federal	—	433	(922)
State	—	353	(136)
	—	786	(1,058)
Total income tax expense (benefit)	$—	$460	$(783)

In thousands (including share and unit data)	Class A		Class A-1		Class B	AOCI(1)	Retained Earnings	Total Equity
In thousands (including share and unit data)	Units	$	Units	$	$	AOCI(1)	Retained Earnings	Total Equity
Three Months Ended September 30, 2022
Balances at June 30, 2022	19,495	$7,725	1,843	$28,500	$90	$(84)	$18,859	$55,090
Activity prior to reverse recapitalization
Net Income attributable to Legacy AON Shareholders	—	—	—	—	—	—	5,607	5,607
Equity-based compensation attributable to Legacy AON Shareholders	—	—	—	—	5	—	—	5
Other comprehensive income attributable to Legacy AON Shareholders	—	—	—	—	—	(77)	—	(77)
Balances at September 30, 2022	19,495	$7,725	1,843	$28,500	$95	$(161)	$24,466	$60,625

	As of September 30, 2023	As of December 31, 2022
PNC Facility	$81,250	$81,250
Total	81,250	81,250
Unamortized debt issuance costs	(825)	(949)
Total debt	$80,425	$80,301

Table search / Registration and prospectus / American Oncology Network, Inc.

183 results

Top filers

Top filing types

Recent filing years